Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study

  • Read more about Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study

A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae

  • Read more about A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae

Study of LAU-7b for the Treatment of Long COVID in Adults

  • Read more about Study of LAU-7b for the Treatment of Long COVID in Adults

Expanded Access Program for Revumenib

  • Read more about Expanded Access Program for Revumenib

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

  • Read more about A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers

  • Read more about Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers

Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure: Application to the COVID-19 Pandemic

  • Read more about Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure: Application to the COVID-19 Pandemic

Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19

  • Read more about Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19

The Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy Subjects

  • Read more about The Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy Subjects

Investigation of the Use of a Probiotic Supplement in People With Long COVID

  • Read more about Investigation of the Use of a Probiotic Supplement in People With Long COVID

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 102
  • Page 103
  • Page 104
  • Page 105
  • Current page 106
  • Page 107
  • Page 108
  • Page 109
  • Page 110
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA